Thursday, 9 December 2021
  
Login

Australia's most trusted
source of pharma news

Thursday, 9 December 2021
Ascott
Ascott
Rep training to 'change forever'

Rep training across the Australian pharma industry is being disrupted with experts warning those who don't embrace the change will be left behind.


Roche's $2 billion bet arrives
Targeted oncology drug makes first TGA appearance
TODAY
Drug class contamination fear
Two company's products under a cloud as TGA investigates
TODAY
Yes, meds sovereignty is a race
Lack of Aussie manufacturing options sends business offshore
TODAY
Pharma lifts the lid on WFH
Employees embrace new priorities ahead of work
7 December
Sell-off rumours circle AZ
Reports the company thinking of dipping out of the Covid vax business
December 7
Great Resignation about to bite?
Aussie pharma on the brink of upheaval as pandemic fall out takes hold
6 December
Staff gifts? Who's playing Santa
Companies delivering early Christmas presents to workers
6 November
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (37)

Clinical & Medical, R&D (24)

Regulatory, Pharmacovigilance & QA (8)

Devices (1)

Other (19)

PM blasted for pharma closures
Australia in danger of losing crucial skilled local workers
8 December
Political spat over Pfizer spirals
More emails point to government dithering over vax
8 December
PBS listing winners 2021
Which companies won the most reimbursements
8 December
Gilead snags top Janssen exec
Leader switches companies after more than a decade
8 December
Sanofi's virtual Christmas cheer
Sign of the times as the festive giving season goes digital
8 December
Inclusion programs not helping
Claims 'rampant sexism' in Australian science is getting worse
8 December
Thumbs up for fifth Covid drug
Plans to deploy an Aussie MSL team once Govt supply deal is signed
7 December
PRIME under fire from PRs
Award withheld for two years running sparks industry disquiet
7 December
Blockbusters fend off generics
Court action piles up as companies thrash out patent validity
7 December
Organon makes history, already
Six months young and the company has scored a 'first'
7 December
Janssen's 'queue jumping' plan
New report aims to stop Aussies waiting longer for meds
December 6
Zimmerman lines up new target
Next inquiry delves into a disease affecting thousands of children
6 December
TGA cancels second Christmas
Comirnaty for kids expected to roll out from early January
6 December
AZ, Pfizer add new drugs
TGA approves Pfizer drug ahead of March PBAC meet
6 December
pif 20K
pif 20K
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.